NCT03019965 - Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis | Biotech Hunter

Enrollment

426

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

January 30, 2020

Conditions

Sepsis

Interventions

DRUG

Intermittent Piperacillin/tazobactam

Piperacillin/tazobactam administered in 30 minutes infusion.

DRUG

Continuous Piperacillin/tazobactam

Piperacillin/tazobactam administered in 24 hours infusion.

DRUG

Intermittent Imipenem

Imipenem administered in 60 minutes infusion.

DRUG

Extended Imipenem

Imipenem administered in 6 hours infusion.

DRUG

Intermittent Meropenem

Meropenem administered in 60 minutes infusion.

DRUG

Extended Meropenem

Meropenem administered in 8 hours infusion.

Trial Locations (2)

Hospital Infantil de México Federico Gómez, Mexico City

Instituto Mexicano del Seguro Social, Mexico City

All Listed Sponsors

collaborator

Instituto Mexicano del Seguro Social

OTHER_GOV

collaborator

Hospital Infantil de Mexico Federico Gomez

OTHER

collaborator

Hospital Regional de Alta Especialidad del Bajio

OTHER

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV